IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-20088

  1. 3,625 Posts.
    lightbulb Created with Sketch. 1841
    Let the Pharmaceutical and Regulatory arm of Incannex do its job and you will be far better of than 20% return through litigation.....and then your up against plaintiffs with deep pockets.

    Q4 will be upon us with RePosa interims and 675A data released. Plus you never know what BC has up his sleeves as more FDA hurdles are removed.

    GL @Ashfield with you endeavour


 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.